Ci Investments Inc. Abb Vie Inc. Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 188,497 shares of ABBV stock, worth $33.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

188,497

Previous 190,789 1.2%

Holding current value

$33.1 Million

Previous $32.7 Million 13.75%

% of portfolio

0.14%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $375,521 - $456,864	-2,292 Reduced 1.2%	188,497 $37.2 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $3.67 Million - $4.29 Million	-23,741 Reduced 11.07%	190,789 $32.7 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $4.47 Million - $5.09 Million	27,953 Added 14.98%	214,530 $39.1 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $7.58 Million - $8.54 Million	55,110 Added 41.92%	186,577 $28.9 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1.33 Million - $1.54 Million	-9,944 Reduced 7.03%	131,467 $19.6 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $1.45 Million - $1.8 Million	10,913 Added 8.36%	141,411 $19.1 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $7.69 Million - $8.86 Million	-53,203 Reduced 28.96%	130,498 $20.8 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $592,243 - $710,255	4,282 Added 2.39%	183,701 $29.7 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $320,627 - $367,738	2,389 Added 1.35%	179,419 $24.1 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $75.3 Million - $95.7 Million	-546,862 Reduced 75.54%	177,030 $27.1 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $23.1 Million - $28.7 Million	175,383 Added 31.97%	723,892 $117 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $16.1 Million - $20.4 Million	149,960 Added 37.63%	548,509 $74.3 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $37.8 Million - $42.9 Million	355,467 Added 825.09%	398,549 $43 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $1.86 Million - $2.07 Million	-17,645 Reduced 29.06%	43,082 $4.85 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $1.3 Million - $1.43 Million	-12,708 Reduced 17.31%	60,727 $6.57 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $2 Million - $2.7 Million	-24,849 Reduced 25.28%	73,435 $7.87 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $666,833 - $782,642	7,762 Added 8.57%	98,284 $8.61 Million
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $296,708 - $397,039	-4,044 Reduced 4.28%	90,522 $8.89 Million
Q1 2020 Aug 07, 2020	SELL	$64.5 - $97.79 $244,842 - $371,210	-3,796 Reduced 3.86%	94,566 $7.21 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $600,049 - $750,789	-8,319 Reduced 7.8%	98,362 $8.71 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $6.72 Million - $8.08 Million	106,681 New	106,681 $8.08 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Abb Vie Inc. Transaction History